In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

BACKGROUND: Approximately fifty percent of patients with acute myeloid leukemia can be cured with current therapeutic strategies which include, standard dose chemotherapy for patients at standard risk of relapse as assessed by cytogenetic and molecular analysis, or high-dose chemotherapy with alloge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Minagawa, Kentaro, Jamil, Muhammad O., AL-Obaidi, Mustafa, Pereboeva, Larisa, Salzman, Donna, Erba, Harry P., Lamb, Lawrence S., Bhatia, Ravi, Mineishi, Shin, Di Stasi, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5132227/
https://ncbi.nlm.nih.gov/pubmed/27907031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0166891
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados